Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Motocitee Industries was a Canadian federal corporation that appears to have operated primarily as a supplier and distributor rather than a drug-development biotech company. Publicly available evidence links the company to the supply of personal protective equipment for healthcare customers during the COVID-19 period, including mention as a Health Canada approved supplier in partnership-related announcements. There is no evidence of a therapeutic pipeline, proprietary drug candidates, or clinical-stage biopharma R&D programs. Based on available information, the company fit better within healthcare supply and PPE distribution than biotech, pharma, or medtech innovation. Corporate registry records indicate the entity was incorporated in 2014 and later dissolved in 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Motocitee Industries.